63438-08-4 = 90293-01-9 [标题:Reaction Conditions 标题:Pharmaceutical Compositions Containing 2-(4-Methylaminobutoxy)Diphenylmethane For Improvement And/or Treatment Of Mental Symptoms Caused By Organic Disorder In Brain 参考文献:European Patent Organization
📜苯甲基苯酚置于氢氧化钾体系中,用 甲醇,乙醇,水 作为反应溶剂,化学反应 32.0H,反应生成 双芬麦兰 参考文献:Synthesis And Antidepressant Activity Of Substituted (.Omega.-Aminoalkoxy)Benzene Derivatives 标题:Synthesis And Antidepressant Activity Of Substituted (.Omega.-Aminoalkoxy)Benzene Derivatives 摘要:A Series Of Substituted (Omega-Aminoalkoxy)Benzene Derivatives Has Been Synthesized And Screened For Potential Antidepressant Activities. The Effect Of Structural Variation Of These Molecules Has Been Systematically Examined. Antidepressant Activity Was Clearly Displayed By 2-Benzyl-1-[4-(Methylamino)Butoxy]Benzene (7),2-(2-Hydroxybenzyl)-1-[4-(Methylamino)Butoxy]Benzene (19),1-[4-(Methylamino)Butoxy]-2-Phenoxybenzene (29),And 1-[4-(Methylamino)Butoxy]-2-(Phenylthio)Benzene (31) In Further Pharmacological Studies. These Compounds Did Not Possess The Anticholinergic,Antihistaminic,And Muscle-Relaxant Side Effects Common To Tricyclic Antidepressants. DOI:10.1021/jm00134A004
专利号:US-7576211-B2 优先权日:2004-09-30 标题 :Synthesis of thienopyridinone compounds and related intermediates 发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; CHEN DONGLI; MARANTZ YAEL; SHACHAM SHARON; HEIFETZ ALEXANDER; INBAL BOAZ; BAR-HAIM SHAY; MOHANTY PRADYUMNA; LOBERA MERCEDES; WU LAURENCE 权利人:EPIX DELAWARE INC 摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
专利号:US-2006084805-A1 优先权日:2004-09-30 标题:Synthesis of thienopyridinone compounds and related intermediates
专利号:US-7982040-B2 优先权日:2004-05-17 标题 :Thienopyridinone compounds and methods of treatment 发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; MOHANTY PRADYUMNA; CHEN DONGLI; LOBERA MERCEDES; WU LAURENCE; MARANTZ YAEL; INBAL BOAZ; HEIFETZ ALEXANDER; BAR-HAIM SHAY; SHACHAM SHARON 权利人:NANOTHERAPEUTICS INC 摘要:The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
专利号:US-9751877-B2 优先权日:2012-09-21 标题 :Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegenerative and neurological disorders 发明人:PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; GREEN MICHAEL ERIC; PATEL NANDINI CHATURBHAI; STIFF CORY MICHAEL; TRAN TUAN PHONG; KAUFFMAN GREGORY WAYNE; STEPAN ANTONIA FRIEDERIKE; VERHOEST PATRICK ROBERT 权利人:PFIZER 摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
专利号:US-2004138238-A1 优先权日:2002-08-08 标题 :Substituted aminopyrimidine compounds as neurokinin antagonists 发明人:DHANOA DALE S; BECKER OREN; NOIMAN SILVIA; KESAVAN VENKITASAMY; SHARADENDU ANURAG; MOHANTY PRADYUMNA; CHEN DONGLI; CHERUKU SRINIVASA RAO; HEIFETZ ALEXANDER; KALID ORI; MARANTZ YAEL; NUDELMAN RAPHAEL; SBACHAM SHARON; BAR-HAIM SHAY 摘要:The invention discloses tachykinin receptor antagonists. The tachykinin family of receptors comprising the neurokinins substance P (SP), neurokinin A, and neurokinin B and related neuropeptides that are widely distributed in the peripheral and central nervous system. The invention discloses novel aminopyrimidine derivatives, synthesis and uses thereof for the treatment of diseases mediated directly or indirectly by the tachykinin receptors. These diseases include central nervous system disorders such as anxiety, pain, depression, emesis, in particular cancer chemotherapy induced emesis, respiratory and inflammatory bowel disease and other gastric disorders, asthma, schizophrenia, ophthalmic diseases such as glaucoma, ocular hypotension, neural injury, stroke, cardiac disorders, psoriasis, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.
专利号:US-9550795-B2 优先权日:2011-08-31 标 题:Hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds 发明人:BRODNEY MICHAEL AARON; BUTLER CHRISTOPHER RYAN; HELAL CHRISTOPHER JOHN; O'NEILL BRIAN THOMAS 权利人:BRODNEY MICHAEL AARON; BUTLER CHRISTOPHER RYAN; HELAL CHRISTOPHER JOHN; O'NEILL BRIAN THOMAS; PFIZER 摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I, n nas defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
参考文献:10.1016/0168-0102(95)01017-3 摘要:Kondo Y, Ogawa N, Asanuma M, Matsuura K, Nishibayashi K, Iwata E. Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion. Neurosci Res. 1996 Mar;24(4):409–14. doi: 10.1016/0168-0102(95)01017-3. 参考文献:10.1023/a:1020953913490 摘要:Miyazaki I, Iwata-Ichikawa E, Asanuma M, Iida M, Ogawa N. Bifemelane hydrochloride protects against cytotoxicity of hydrogen peroxide on cultured rat neuroblastoma cell line. Neurochem Res. 1999 Jul;24(7):857–60. doi: 10.1023/a:1020953913490. 参考文献:10.1254/fpj.99.123 摘要:Hokonohara T, Shinoda Y, Hori N. [Effects of oxiracetam on the decrease in population spikes in hypoxic and low glucose media]. Nihon Yakurigaku Zasshi. 1992 Mar;99(3):123–33. doi: 10.1254/fpj.99.123. 参考文献:10.1016/0091-3057(92)90020-g 摘要:Nomura M. Effects of bifemelane on discrimination learning of serotonergic-dysfunction rats. Pharmacology Biochemistry and Behavior. 1992 Aug;42(4):721–31. doi: 10.1016/0091-3057(92)90020-g. 参考文献:10.1023/a:1027369119224 摘要:Kabuto H, Asanuma M, Nishibayashi S, Iida M, Ogawa N. Chronic administration of Oren-gedoku-to (TJ15) inhibits ischemia-induced changes in brain indoleamine metabolism and muscarinic receptor binding in the Mongolian gerbil. Neurochem Res. 1997 Jan;22(1):33–6. doi: 10.1023/a:1027369119224.